Franklin Resources
ARCT icon

Franklin Resources’s Arcturus Therapeutics ARCT Stock Holding History

Franklin Resources’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-49,384
Closed -$910K – 3126
2025
Q3 		$910K Sell
49,384
-472
-0.9% -$7.58K ﹤0.01% 2155
2025
Q2 		$649K Buy
49,856
+79
+0.2% +$934 ﹤0.01% 2203
2025
Q1 		$527K Sell
49,777
-50,900
-51% -$808K ﹤0.01% 2243
2024
Q4 		$1.71M Sell
100,677
-3,259
-3% -$61.4K ﹤0.01% 1784
2024
Q3 		$2.17M Buy
103,936
+36,714
+55% +$785K ﹤0.01% 1714
2024
Q2 		$1.64M Sell
67,222
-3,424
-5% -$104K ﹤0.01% 1762
2024
Q1 		$2.39M Buy
70,646
+54,848
+347% +$1.94M ﹤0.01% 1658
2023
Q4 		$498K Sell
15,798
-8
-0.1% -$190 ﹤0.01% 1944
2023
Q3 		$404K Sell
15,806
-3,257
-17% -$100K ﹤0.01% 2025
2023
Q2 		$547K Buy
+19,063
New +$519K ﹤0.01% 1929
2018
Q2 		– Sell
-56,711
Closed -$312K – 1470
2018
Q1 		$312K Sell
56,711
-582,931
-91% -$4.02M ﹤0.01% 1412
2017
Q4 		$5.09M Sell
639,642
-1
-0% -$9 ﹤0.01% 1064
2017
Q3 		$4.52M Hold
639,643
– – ﹤0.01% 1071
2017
Q2 		$5.01M Hold
639,643
– – ﹤0.01% 1081
2017
Q1 		$5.1M Hold
639,643
– – ﹤0.01% 1102
2016
Q4 		$9.4M Buy
639,643
+72,724
+13% +$1.09M ﹤0.01% 969
2016
Q3 		$9.8M Buy
566,919
+45,072
+9% +$1.46M 0.01% 980
2016
Q2 		$16.4M Hold
521,847
– – 0.01% 857
2016
Q1 		$13.8M Buy
521,847
+114,907
+28% +$3.89M 0.01% 895
2015
Q4 		$17.9M Buy
406,940
+155,426
+62% +$7M 0.01% 869
2015
Q3 		$10.6M Buy
251,514
+43,357
+21% +$2.28M 0.01% 1006
2015
Q2 		$9.53M Buy
+208,157
New +$9.54M ﹤0.01% 1049

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Franklin Resources's ARCT Position: Q4 2025 in Review

Franklin Resources sold out of Arcturus Therapeutics (ARCT) in Q4 2025, closing a stake of 49,384 shares — an estimated $910K sold.

Franklin Resources first reported a position in ARCT in Q2 2015 and held it in 22 quarters. The position peaked at $17.9M in Q4 2015. 120 funds tracked by Wall St. Rank hold ARCT as of Q4 2025.

  • Franklin Resources reported no remaining Arcturus Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Franklin Resources sold 49,384 Arcturus Therapeutics shares in Q4 2025, an estimated $910K.
  • Franklin Resources first reported a position in Arcturus Therapeutics in Q2 2015 and held it in 22 quarters.
  • Franklin Resources's Arcturus Therapeutics position peaked at $17.9M in Q4 2015.
  • 120 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q4 2025.

Based on Franklin Resources's 13F filing for Q4 2025, filed 11 Feb 2026.